Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 3.65%
March 31, 2026 0.19%
December 31, 2025 -3.57%
September 30, 2025 1.09%
June 30, 2025 0.77%
March 31, 2025 9.24%
December 31, 2024 10.59%
September 30, 2024 13.11%
June 30, 2024 16.72%
March 31, 2024 12.63%
December 31, 2023 8.21%
September 30, 2023 13.28%
June 30, 2023 3.11%
March 31, 2023 -3.92%
December 31, 2022 20.47%
September 30, 2022 1.92%
June 30, 2022 -10.83%
March 31, 2022 -24.67%
December 31, 2021 1.28%
Date Value
September 30, 2021 -20.61%
June 30, 2021 -16.78%
March 31, 2021 -11.27%
December 31, 2020 -35.94%
September 30, 2020 -12.60%
June 30, 2020 -9.57%
March 31, 2020 12.59%
December 31, 2019 -12.95%
September 30, 2019 5.60%
June 30, 2019 2.79%
March 31, 2019 -1.29%
December 31, 2018 -11.75%
September 30, 2018 -1.34%
June 30, 2018 -6.16%
March 31, 2018 -14.81%
December 31, 2017 -69.56%
September 30, 2017 -20.52%
June 30, 2017 -3.41%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Getinge AB 49.35%
Xvivo Perfusion AB 63.23%
Abbott Laboratories 52.64%
AngioDynamics, Inc. 56.00%
Alphatec Holdings, Inc. 62.90%

Gross Profit Margin (Quarterly) Related Metrics